Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

April 30, 2026

Conditions

Relapsed CancerGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Interventions

BIOLOGICAL

Relapsed glioblastoma

Paired tumor samples diagnosis/relapse

Trial Locations (1)

RECRUITING

CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale, Bordeaux

All Listed Sponsors

lead

University Hospital, Bordeaux

OTHER